HeartSciences (HSCS) EBT Margin (2021 - 2025)

HeartSciences (HSCS) has reported EBT Margin for 5 consecutive years, with 97269.0% the latest figure, recorded in Q4 2025.

• Quarterly EBT Margin changed N/A year-over-year to 97269.0% in Q4 2025, while the trailing twelve-month figure through Apr 2026 was 283247.04% (down 1659773.0% YoY) and the FY2026 annual result came in at 596553.65%, down 5900732.0% from the prior year.
• EBT Margin advanced to 97269.0% in Q4 2025 per HSCS's latest filing, from 912409.63% in the prior quarter.
• Over the last five years, EBT Margin for HSCS reached as high as 10048.78% in Q3 2021 and fell as low as 912409.63% in Q3 2025.
• A 5-year average of 262579.64% and a median of 97280.54% in 2024 frame the typical range for EBT Margin.
• Annual changes were most pronounced in 2023 — EBT Margin tumbled 59235836 bps — and 2024, when it soared 54029817 bps.
• Year by year, EBT Margin stood at 10048.78% in 2021, then sank by 3586 bps to 370391.66% in 2022, then gained by 3 bps to 357732.28% in 2023, then jumped by 73 bps to 97292.09% in 2024, then increased by 0 bps to 97269.0% in 2025.
• According to Business Quant data, EBT Margin over the past three periods registered 97269.0%, 912409.63%, and 48304.62% for Q4 2025, Q3 2025, and Q2 2025 respectively.